Debt-to-equity of HeartSciences Inc. from 31 Jan 2023 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
HeartSciences Inc. quarterly Debt-to-equity in % history and change rate from 31 Jan 2023 to 31 Oct 2025.
  • HeartSciences Inc. Debt-to-equity for the quarter ending 31 Oct 2025 was 140%, a 250% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

HeartSciences Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 140% +100% +250% 31 Oct 2025
Q2 2025 164% +111% +212% 31 Jul 2025
Q1 2025 117% +33% +40% 30 Apr 2025
Q4 2024 64% -121% -66% 31 Jan 2025
Q3 2024 40% +674% 31 Oct 2024
Q2 2024 53% -2487% -98% 31 Jul 2024
Q1 2024 83% -251% -75% 30 Apr 2024
Q4 2023 185% +963% 31 Jan 2024
Q3 2023 -634% 31 Oct 2023
Q2 2023 2539% 31 Jul 2023
Q1 2023 334% 30 Apr 2023
Q4 2022 -779% 31 Jan 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.